Mariotti G - Search Results

1

Regenerative Medicine-Based Treatment of Stress Urinary Incontinence with Mesenchymal Stem Cells: A Systematic Review and Meta-analysis.

Mariotti G, Salciccia S, Viscuso P, Bevilacqua G, Casale P, Frisenda M, Di Pierro GB, Cattarino S, Gentilucci A, Rosati D, Sciarra B, Sciarra A. Mariotti G, et al. Curr Stem Cell Res Ther. 2023;18(3):429-437. doi: 10.2174/1574888X17666220616100621. Curr Stem Cell Res Ther. 2023. PMID: 35713128

2

Histopathological aspects associated with the diagnosis of benign prostatic hyperplasia: clinical implications.

Sciarra A, Voria G, Mariotti G, Gentile V, Pastore A, Di Silverio F. Sciarra A, et al. Among authors: mariotti g. Urol Int. 2002;69(4):253-62. doi: 10.1159/000066128. Urol Int. 2002. PMID: 12444279 Review. No abstract available.

3

Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis.

Di Silverio F, Gentile V, De Matteis A, Mariotti G, Giuseppe V, Luigi PA, Sciarra A. Di Silverio F, et al. Among authors: mariotti g. Eur Urol. 2003 Feb;43(2):164-75. doi: 10.1016/s0302-2838(02)00548-1. Eur Urol. 2003. PMID: 12565775

4

Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable?

Sciarra A, Mariotti G, Gentile V, Voria G, Pastore A, Monti S, Di Silverio F. Sciarra A, et al. Among authors: mariotti g. BJU Int. 2003 Mar;91(5):438-45. doi: 10.1046/j.1464-410x.2003.03066.x. BJU Int. 2003. PMID: 12603395 Review. No abstract available.

5

Variation of chromogranin A serum levels after radical retropubic prostatectomy for prostate adenocarcinoma.

Sciarra A, Gentile V, Monti S, Mariotti G, Pastore A, Di Silverio F. Sciarra A, et al. Among authors: mariotti g. Arch Androl. 2003 Jan-Feb;49(1):39-48. doi: 10.1080/01485010390129160. Arch Androl. 2003. PMID: 12647777 Clinical Trial.

6

Role of radical retropubic prostatectomy in patients with locally advanced prostate cancer: the influence of Gleason score 8-10.

Sciarra A, Gentile V, Voria G, Mariotti G, Seccareccia F, Pastore A, Di Silverio F. Sciarra A, et al. Among authors: mariotti g. Urol Int. 2003;70(3):186-94. doi: 10.1159/000068777. Urol Int. 2003. PMID: 12660455

7

Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma.

Sciarra A, Monti S, Gentile V, Mariotti G, Cardi A, Voria G, Lucera R, Di Silverio F. Sciarra A, et al. Among authors: mariotti g. Prostate. 2003 May 15;55(3):168-79. doi: 10.1002/pros.10222. Prostate. 2003. PMID: 12692782 Clinical Trial.

8

Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive value of serum chromogranin A.

Sciarra A, Voria G, Monti S, Mazzone L, Mariotti G, Pozza M, D'Eramo G, Silverio FD. Sciarra A, et al. Among authors: mariotti g. Prostate. 2004 Mar 1;58(4):421-8. doi: 10.1002/pros.10347. Prostate. 2004. PMID: 14968443

9

Benign prostatic hyperplasia: what about a campaign for prevention?

Di Silverio F, Gentile V, Pastore AL, Voria G, Mariotti G, Sciarra A. Di Silverio F, et al. Among authors: mariotti g. Urol Int. 2004;72(3):179-88. doi: 10.1159/000077112. Urol Int. 2004. PMID: 15084759 Review.

10

Histopathological aspects of transitional cell carcinoma of the bladder: analysis of 20 years experience.

Sciarra A, De Matteis A, Mariotti G, Voria G, Lucera R, Di Silverio F. Sciarra A, et al. Among authors: mariotti g. Int J Urol. 2004 Jul;11(7):467-75. doi: 10.1111/j.1442-2042.2004.00834.x. Int J Urol. 2004. PMID: 15242354 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters